type 2 diabetes
Conditions
Interventions
Patients in intervention group were able to have doctors'
instruction with SMBG data-management system (HR Joint Simle Data Vision), a SMBG readings analyzer using a software that provides comprehensive summary statistics, listings and graphical spots of blo
Sponsors
Center for Diabetes, Endocrinology and Metabolism, Kansai Electric Power Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Eligible patients included 1) those with T2D aged 20 years or older and younger than 75 years, 2) those using SMBG for more than 3 months; 3) those with HbA1c 7.0 % or higher and lower than 11.0 %; 4) those capable of answering the questionnaires used in the present study; and 5) those receiving insulin and/or GLP-1 receptor agonist (GLP-1RA) as SMBG is allowed for those using injectables under the Japanese national health insurance coverage.
Exclusion criteria
Exclusion criteria: Patients were excluded if they were 1) susceptible to dementia and/or psychological and/or psychiatric disorders; 2) receiving only GLP-1RA as an injection therapy; or 3) considered to be ineligible for this study by physicians-in-charge.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary end points of this study were change in HbA1c levels from baseline to 6-month and change in DTR-QOL score from baseline to 6-month. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes were included as follows: change in body weight; SMBG frequency; change in insulin doses; changes in scores of the original SMBG questionnaire. | — |
Countries
Japan
Contacts
Public ContactNagaaki Tanaka
Kansai Electric Power Medical Institute Yutaka Seino Distinguished Center for Diabetes Research
Outcome results
None listed